- Report
- February 2024
- 175 Pages
Global
From €4828EUR$5,000USD£4,088GBP
- Report
- February 2024
- 112 Pages
Global
From €4586EUR$4,750USD£3,883GBP
- Report
- July 2023
- 135 Pages
Global
From €7241EUR$7,500USD£6,132GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1931EUR$2,000USD£1,635GBP
- Report
- July 2023
- 67 Pages
Global
From €3814EUR$3,950USD£3,229GBP
- Report
- June 2023
- 204 Pages
Global
From €3476EUR$3,600USD£2,943GBP
- Report
- November 2018
- 147 Pages
Global
From €1328EUR$1,375USD£1,124GBP
€2655EUR$2,750USD£2,248GBP
- Report
- January 2022
- 121 Pages
Global
From €4586EUR$4,750USD£3,883GBP
- Drug Pipelines
- September 2020
- 79 Pages
Global
From €1931EUR$2,000USD£1,635GBP
The Drug Overdose market is a subset of the Addiction Disorders Drugs market, which focuses on the treatment of substance abuse and addiction. This market includes a variety of drugs, such as opioids, stimulants, and depressants, which are used to treat addiction and overdose. These drugs are used to reduce the risk of overdose and to help individuals recover from addiction. The market also includes products such as naloxone, which is used to reverse the effects of an opioid overdose.
The Drug Overdose market is a rapidly growing market, driven by the increasing prevalence of addiction and overdose. The market is expected to continue to grow as more individuals seek treatment for addiction and overdose.
Companies in the Drug Overdose market include Purdue Pharma, Reckitt Benckiser, GlaxoSmithKline, Johnson & Johnson, and Novartis. Show Less Read more
